As of 2024-12-15, the Relative Valuation of Creo Medical Group PLC (CREO.L) is (136.30) GBP. This relative valuation is based on P/E multiples. With the latest stock price at 16.87 GBP, the upside of Creo Medical Group PLC based on Relative Valuation is -907.7%.
The range of the Relative Valuation is (150.13) - (134.33) GBP.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 23.8x | 21.4x |
| Forward P/E multiples | 26.6x - 27.3x | 27.0x |
| Fair Price | (150.13) - (134.33) | (136.30) |
| Upside | -989.7% - -896.0% | -907.7% |
| Date | P/E |
| 2024-12-13 | -2.99 |
| 2024-12-12 | -2.88 |
| 2024-12-11 | -2.50 |
| 2024-12-10 | -2.52 |
| 2024-12-09 | -2.57 |
| 2024-12-06 | -2.61 |
| 2024-12-05 | -2.64 |
| 2024-12-04 | -2.70 |
| 2024-12-03 | -2.77 |
| 2024-12-02 | -2.83 |
| 2024-11-29 | -2.83 |
| 2024-11-28 | -2.83 |
| 2024-11-27 | -2.83 |
| 2024-11-26 | -2.83 |
| 2024-11-25 | -2.86 |
| 2024-11-22 | -2.95 |
| 2024-11-21 | -2.86 |
| 2024-11-20 | -2.88 |
| 2024-11-19 | -2.97 |
| 2024-11-18 | -2.97 |
| 2024-11-15 | -3.06 |
| 2024-11-14 | -2.99 |
| 2024-11-13 | -3.10 |
| 2024-11-12 | -3.23 |
| 2024-11-11 | -3.30 |
| 2024-11-08 | -3.19 |
| 2024-11-07 | -3.14 |
| 2024-11-06 | -3.23 |
| 2024-11-05 | -3.32 |
| 2024-11-04 | -3.32 |
| 2024-11-01 | -3.46 |
| 2024-10-31 | -3.48 |
| 2024-10-30 | -3.54 |
| 2024-10-29 | -3.50 |
| 2024-10-28 | -3.54 |
| 2024-10-25 | -3.54 |
| 2024-10-24 | -3.54 |
| 2024-10-23 | -3.59 |
| 2024-10-22 | -3.59 |
| 2024-10-21 | -3.59 |
| 2024-10-18 | -3.59 |
| 2024-10-17 | -3.69 |
| 2024-10-16 | -3.68 |
| 2024-10-15 | -3.77 |
| 2024-10-14 | -3.96 |
| 2024-10-11 | -3.94 |
| 2024-10-10 | -3.94 |
| 2024-10-09 | -3.94 |
| 2024-10-08 | -3.96 |
| 2024-10-07 | -3.84 |